An enrichment of transcriptional pathways involving proliferation (E2F targets and G2M checkpoint), PI3K/ATK/mTOR and p53 signaling have also been described in TFE3-tRCC [20]. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.